Redwood Scientific Technologies Inc
Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California.
Redwood Scientific Technologies Inc (RSCI) - Net Assets
Latest net assets as of December 2023: $-194.61K USD
Based on the latest financial reports, Redwood Scientific Technologies Inc (RSCI) has net assets worth $-194.61K USD as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($296.47K) and total liabilities ($491.08K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-194.61K |
| % of Total Assets | -65.64% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Redwood Scientific Technologies Inc - Net Assets Trend (2009–2023)
This chart illustrates how Redwood Scientific Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Redwood Scientific Technologies Inc (2009–2023)
The table below shows the annual net assets of Redwood Scientific Technologies Inc from 2009 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-194.61K | -35.41% |
| 2022-12-31 | $-143.71K | -- |
| 2021-12-31 | $0.00 | -- |
| 2020-12-31 | $0.13 | +100.00% |
| 2017-12-31 | $-718.63K | +36.72% |
| 2016-12-31 | $-1.14 Million | -66.16% |
| 2015-12-31 | $-683.42K | -79.41% |
| 2014-12-31 | $-380.93K | +83.66% |
| 2011-12-31 | $-2.33 Million | -55.88% |
| 2010-12-31 | $-1.50 Million | -99.81% |
| 2009-12-31 | $-748.38K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Redwood Scientific Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 790345200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $205.76K | % |
| Other Components | $8.36 Million | % |
| Total Equity | $-194.61K | 100.00% |
Redwood Scientific Technologies Inc Competitors by Market Cap
The table below lists competitors of Redwood Scientific Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Birlesim Grup Enerji
IS:BIGEN
|
$2.39K |
|
Sincerity Applied Materials Holdings Corp
PINK:SINC
|
$2.39K |
|
A Soriano Corp
PSE:ANS
|
$2.40K |
|
MEDICAL DEVTS INTL
BE:M5D
|
$2.40K |
|
Hapugastenne Plantations PLC
CM:HAPUN0000
|
$2.39K |
|
LT Group Inc
PSE:LTG
|
$2.39K |
|
DOLPHIN CAP INVEST
BE:D5S
|
$2.39K |
|
Profit Planners Management Inc
PINK:PPMT
|
$2.38K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Redwood Scientific Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -143,712 to -194,606, a change of -50,894.
- Net loss of 3,481,894 reduced equity.
- New share issuances of 1,440,000 increased equity.
- Other factors increased equity by 1,991,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.48 Million | -1789.2% |
| Share Issuances | $1.44 Million | +739.96% |
| Other Changes | $1.99 Million | +1023.09% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Redwood Scientific Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $-6.73 | $0.24 | x |
| 2017-12-31 | $-4.26 | $0.24 | x |
| 2020-12-31 | $0.00 | $0.24 | x |
| 2021-12-31 | $-0.03 | $0.24 | x |
| 2022-12-31 | $0.00 | $0.24 | x |
| 2023-12-31 | $0.00 | $0.24 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Redwood Scientific Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-3792615.38%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 0.00% | -51.62% | 0.55x | 0.00x | $-165.47K |
| 2010 | 0.00% | -385.83% | 0.25x | 0.00x | $-707.30K |
| 2011 | 0.00% | -361.42% | 0.31x | 0.00x | $-727.47K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $55.68K |
| 2015 | 0.00% | -534.68% | 0.08x | 0.00x | $62.24K |
| 2016 | 0.00% | -19.30% | 2.49x | 0.00x | $-900.87K |
| 2017 | 0.00% | 1.21% | 2.64x | 0.00x | $165.40K |
| 2020 | -37926153.85% | 0.00% | 0.00x | 0.00x | $-49.30K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-129.34K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.46 Million |
Industry Comparison
This section compares Redwood Scientific Technologies Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $439,452,927
- Average return on equity (ROE) among peers: -31.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Redwood Scientific Technologies Inc (RSCI) | $-194.61K | 0.00% | N/A | $2.39K |
| Ascend Wellness Holdings Inc (AAWH) | $71.80 Million | -118.37% | 11.54x | $48.90 Million |
| AB Science S.A (ABSCF) | $-21.01 Million | 0.00% | 0.00x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-294.68K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $195.20 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $29.91 Million | 0.00% | 0.07x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.72 Million | -18.78% | 0.11x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $20.08 Million | -10.91% | 0.33x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.85 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.25 Billion | 5.19% | 0.72x | $85.61 Million |